Correlation between penicillin-binding protein 2 mutations and carbapenem resistance in Escherichia coli

Journal of Medical Microbiology

Volumn 62, Issue PART3, 2013, Pages 429-436

  Yamachika, Shinichiro ^a   Sugihara, Chika ^a   Kamai, Yasuki ^a   Yamashita, Makoto ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BETA LACTAM; BIAPENEM; CARBAPENEM; DORIPENEM; IMIPENEM; MEROPENEM; PANIPENEM; PENICILLIN BINDING PROTEIN 2; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL MUTATION; BACTERIUM ISOLATION; CONTROLLED STUDY; CORRELATION ANALYSIS; ESCHERICHIA COLI; MUTATION RATE; NONHUMAN; PRIORITY JOURNAL;

CARBAPENEMS; DNA REPAIR; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; GENE EXPRESSION REGULATION, BACTERIAL; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; MUTATION; MUTS DNA MISMATCH-BINDING PROTEIN; PENICILLIN-BINDING PROTEINS;

EID: 84874203016     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.051631-0     Document Type: Article

References (28)

1. Asahi, Y., Takeuchi, Y. & Ubukata, K. (1999). Diversity of substitutions within or adjacent to conserved amino acid motifs of penicillin-binding protein 2X in cephalosporin-resistant Streptococcus pneumoniae isolates. Antimicrob Agents Chemother 43, 1252-1255.
2. Boe, L., Danielsen, M., Knudsen, S., Petersen, J. B., Maymann, J. & Jensen, P. R. (2000). The frequency of mutators in populations of Escherichia coli. Mutat Res 448, 47-55.
3. Chopra, I., O'Neill, A. J. & Miller, K. (2003). The role of mutators in the emergence of antibiotic-resistant bacteria. Drug Resist Updat 6, 137-145.
4. Datsenko, K. A. & Wanner, B. L. (2000). One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97, 6640-6645.
5. Davies, T. A., Shang, W., Bush, K. & Flamm, R. K. (2008). Affinity of doripenem and comparators to penicillin-binding proteins in Escherichia coli and Pseudomonas aeruginosa. Antimicrob Agents Chemother 52, 1510-1512.
6. Denamur, E., Bonacorsi, S., Giraud, A., Duriez, P., Hilali, F., Amorin, C., Bingen, E., Andremont, A., Picard, B. & other authors (2002). High frequency of mutator strains among human uropathogenic Escherichia coli isolates. J Bacteriol 184, 605-609.
7. Grebe, T. & Hakenbeck, R. (1996). Penicillin-binding proteins 2b and 2x of Streptococcus pneumoniae are primary resistance determinants for different classes of β-lactam antibiotics. Antimicrob Agents Chemother 40, 829-834.
8. Hedge, P. J. & Spratt, B. G. (1985). Amino acid substitutions that reduce the affinity of penicillin-binding protein 3 of Escherichia coli for cephalexin. Eur J Biochem 151, 111-121.
9. Horst, J.-P., Wu, T.-H. & Marinus, M. G. (1999). Escherichia coli mutator genes. Trends Microbiol 7, 29-36.
10. Jones, R. N., Huynh, H. K. & Biedenbach, D. J. (2004). Activities of doripenem (S-4661) against drug-resistant clinical pathogens. Antimicrob Agents Chemother 48, 3136-3140.
11. Koronakis, V., Eswaran, J. & Hughes, C. (2004). Structure and function of TolC: the bacterial exit duct for proteins and drugs. Annu Rev Biochem 73, 467-489.
12. Livermore, D. M., Sefton, A. M. & Scott, G. M. (2003). Properties and potential of ertapenem. J Antimicrob Chemother 52, 331-344.
13. Maciá, M. D., Blanquer, D., Togores, B., Sauleda, J., Pérez, J. L. & Oliver, A. (2005). Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections. Antimicrob Agents Chemother 49, 3382-3386.
14. Masuda, N. & Church, G. M. (2002). Escherichia coli gene expression responsive to levels of the response regulator EvgA. J Bacteriol 184, 6225-6234.
15. Morero, N. R., Monti, M. R. & Argaraña, C. E. (2011). Effect of ciprofloxacin concentration on the frequency and nature of resistant mutants selected from Pseudomonas aeruginosa mutS and mutT hypermutators. Antimicrob Agents Chemother 55, 3668-3676.
16. NCCLS (2003). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, 6th edn. Approved standard M7-A6. Wayne, PA: National Committee for Clinical Laboratory Standards.
17. Papp-Wallace, K. M., Endimiani, A., Taracila, M. A. & Bonomo, R. A. (2011). Carbapenems: past, present, and future. Antimicrob Agents Chemother 55, 4943-4960.
18. Perry, C. M. & Ibbotson, T. (2002). Biapenem. Drugs 62, 2221-2234.
19. Spratt, B. G. (1978). Escherichia coli resistance to β-lactam antibiotics through a decrease in the affinity of a target for lethality. Nature 274, 713-715.
20. Sulavik, M. C., Houseweart, C., Cramer, C., Jiwani, N., Murgolo, N., Greene, J., DiDomenico, B., Shaw, K. J., Miller, G. H. & other authors (2001). Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump genes. Antimicrob Agents Chemother 45, 1126-1136.
21. Trong, H. N., Prunier, A. L. & Leclercq, R. (2005). Hypermutable and fluoroquinolone-resistant clinical isolates of Staphylococcus aureus. Antimicrob Agents Chemother 49, 2098-2101.
22. Tsuji, M., Ishii, Y., Ohno, A., Miyazaki, S. & Yamaguchi, K. (1998). In vitro and in vivo antibacterial activities of S-4661, a new carbapenem. Antimicrob Agents Chemother 42, 94-99.
23. Watson, M. E., Jr, Burns, J. L. & Smith, A. L. (2004). Hypermutable Haemophilus influenzae with mutations in mutS are found in cystic fibrosis sputum. Microbiology 150, 2947-2958.
24. Yamada, M., Watanabe, T., Baba, N., Takeuchi, Y., Ohsawa, F. & Gomi, S. (2008). Crystal structures of biapenem and tebipenem complexed with penicillin-binding proteins 2X and 1A from Streptococcus pneumoniae. Antimicrob Agents Chemother 52, 2053-2060.
25. Yang, Y., Bhachech, N. & Bush, K. (1995). Biochemical comparison of imipenem, meropenem and biapenem: permeability, binding to penicillin-binding proteins, and stability to hydrolysis by β-lactamases. J Antimicrob Chemother 35, 75-84.
26. Zapun, A., Contreras-Martel, C. & Vernet, T. (2008). Penicillinbinding proteins and β-lactam resistance. FEMS Microbiol Rev 32, 361-385.
27. Zgurskaya, H. I., Krishnamoorthy, G., Ntreh, A. & Lu, S. (2011). Mechanism and function of the outer membrane channel TolC in multidrug resistance and physiology of enterobacteria. Front Microbiol 2, 189.
28. Zhanel, G. G., Wiebe, R., Dilay, L., Thomson, K., Rubinstein, E., Hoban, D. J., Noreddin, A. M. & Karlowsky, J. A. (2007). Comparative review of the carbapenems. Drugs 67, 1027-1052.